Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 6
1995 1
1996 1
1997 2
1999 1
2003 1
2004 1
2006 2
2007 1
2008 1
2009 1
2011 2
2012 4
2013 2
2014 8
2015 6
2016 5
2017 12
2018 12
2019 12
2020 10
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Results by year
Filters applied: . Clear all
Page 1
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.
Orgaz JL, Crosas-Molist E, Sadok A, Perdrix-Rosell A, Maiques O, Rodriguez-Hernandez I, Monger J, Mele S, Georgouli M, Bridgeman V, Karagiannis P, Lee R, Pandya P, Boehme L, Wallberg F, Tape C, Karagiannis SN, Malanchi I, Sanz-Moreno V. Orgaz JL, et al. Among authors: mele s. Cancer Cell. 2020 Jan 13;37(1):85-103.e9. doi: 10.1016/j.ccell.2019.12.003. Cancer Cell. 2020. PMID: 31935375 Free PMC article.
Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.
Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I, Ilieva KM, Cantelli G, Karagiannis P, Mele S, Lam H, Josephs DH, Matias-Guiu X, Marti RM, Nestle FO, Orgaz JL, Malanchi I, Fruhwirth GO, Karagiannis SN, Sanz-Moreno V. Georgouli M, et al. Among authors: mele s. Cell. 2019 Feb 7;176(4):757-774.e23. doi: 10.1016/j.cell.2018.12.038. Epub 2019 Jan 31. Cell. 2019. PMID: 30712866 Free PMC article.
Response to Letter to the Editor.
Straudi S, Baroni A, Mele S, Craighero L, Manfredini F, Lamberti N, Maietti E, Basaglia N. Straudi S, et al. Among authors: mele s. Arch Phys Med Rehabil. 2020 May;101(5):925-926. doi: 10.1016/j.apmr.2020.01.003. Epub 2020 Feb 10. Arch Phys Med Rehabil. 2020. PMID: 32057436 No abstract available.
Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas.
Crisci S, Di Francia R, Mele S, Vitale P, Ronga G, De Filippi R, Berretta M, Rossi P, Pinto A. Crisci S, et al. Among authors: mele s. Front Oncol. 2019 Jun 4;9:443. doi: 10.3389/fonc.2019.00443. eCollection 2019. Front Oncol. 2019. PMID: 31214498 Free PMC article. Review.
Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology.
Crisci S, Amitrano F, Saggese M, Muto T, Sarno S, Mele S, Vitale P, Ronga G, Berretta M, Di Francia R. Crisci S, et al. Among authors: mele s. Medicina (Kaunas). 2019 Jul 28;55(8):414. doi: 10.3390/medicina55080414. Medicina (Kaunas). 2019. PMID: 31357735 Free PMC article. Review.
BRAF inhibitors: resistance and the promise of combination treatments for melanoma.
Griffin M, Scotto D, Josephs DH, Mele S, Crescioli S, Bax HJ, Pellizzari G, Wynne MD, Nakamura M, Hoffmann RM, Ilieva KM, Cheung A, Spicer JF, Papa S, Lacy KE, Karagiannis SN. Griffin M, et al. Among authors: mele s. Oncotarget. 2017 Aug 3;8(44):78174-78192. doi: 10.18632/oncotarget.19836. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100459 Free PMC article. Review.
91 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page